Loading financials from SEC filings…
Pharmaceutical retailers · Healthcare · Fiscal year ends Dec 31
Guardian Pharmacy Services reported revenue of $1.4B in the fiscal year ended Dec 2025, up 17.9% from the year before. Operating income was $73M, an operating margin of 5.0%, and net income was $49M. Operating cash flow of $100M less capital expenditure of $13M left free cash flow of $87M. It held more cash than debt (net cash $66M).
Last 5 fiscal years
| Fiscal year | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue | 1,228 | 1,449 |
| Cost of revenue | 984 | 1,156 |
| Gross profit | 244 | 293 |
| Selling, general & admin | 307 | 220 |
| Operating income | −62.9 | 72.7 |
| Interest expense | 3.3 | 0.7 |
| Pre-tax income | −66.5 | 73.4 |
| Income tax | 4.6 | 24.5 |
| Net income | −110 | 49.2 |
| Fiscal year | Dec 2024 | Dec 2025 |
|---|---|---|
| Cash & equivalents | 4.7 | 65.6 |
| Receivables | 97.2 | 102 |
| Inventory | 40.6 | 43.4 |
| Current assets | 152 | 222 |
| Net PP&E | 49.9 | 55.5 |
| Goodwill | 69.3 | 79.7 |
| Total assets | 321 | 413 |
| Payables | 102 | 116 |
| Current liabilities | 144 | 161 |
| Long-term debt | 0.0 | 0.0 |
| Total liabilities | 171 | 195 |
| Shareholders' equity | 150 | 218 |
| Fiscal year | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating cash flow | 58.0 | 100 |
| Capital expenditure | 14.7 | 13.4 |
| Free cash flow | 43.3 | 86.8 |
| Depreciation & amortisation | 19.8 | 22.3 |
| Stock-based compensation | 131 | 13.9 |
| Fiscal year | Dec 2024 | Dec 2025 |
|---|---|---|
| Revenue growth (YoY) | – | 17.9% |
| Gross margin | 19.9% | 20.2% |
| Operating margin | −5.1% | 5.0% |
| Net margin | −9.0% | 3.4% |
| Return on equityBlank when equity is negative | −73.4% | 22.6% |
| ROCEEBIT ÷ (assets − current liabilities) | −35.6% | 28.9% |
| Free cash flow margin | 3.5% | 6.0% |
| Cash conversion (CFO ÷ net income) | −0.53x | 2.04x |
| Receivable days | 29 | 26 |
| Inventory days | 15 | 14 |
| Payable days | 38 | 37 |
| Interest cover | −19.2x | 109x |
| Debt ÷ equity | 0.00x | 0.00x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | −4.7 | −65.6 |
| Current ratio | 1.05x | 1.38x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.